Sana Biotechnology, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sana Biotechnology, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2025.
  • Sana Biotechnology, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 114 %, a 37.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 114 +31 +37.6% Jun 30, 2025
Q1 2025 94.6 +7.75 +8.92% Mar 31, 2025
Q4 2024 87.7 +3.16 +3.74% Dec 31, 2024
Q3 2024 87.3 +10.9 +14.2% Sep 30, 2024
Q2 2024 82.5 +10.8 +15% Jun 30, 2024
Q1 2024 86.9 +25.7 +41.9% Mar 31, 2024
Q4 2023 84.5 +29.1 +52.6% Dec 31, 2023
Q3 2023 76.4 +22.9 +42.8% Sep 30, 2023
Q2 2023 71.7 +20.7 +40.5% Jun 30, 2023
Q1 2023 61.2 +13.7 +28.9% Mar 31, 2023
Q4 2022 55.4 +8.18 +17.3% Dec 31, 2022
Q3 2022 53.5 -13.8 -20.4% Sep 30, 2022
Q2 2022 51.1 Jun 30, 2022
Q1 2022 47.5 Mar 31, 2022
Q4 2021 47.2 Dec 31, 2021
Q3 2021 67.3 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.